TAM
UTHR icon

Tocqueville Asset Management’s United Therapeutics UTHR Stock Holding History

Tocqueville Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9M Buy
71,878
+11,595
+19% +$6.53M 0.51% 53
2026
Q1 		$35.7M Sell
60,283
-860
-1% -$428K 0.53% 53
2025
Q4 		$29.8M Sell
61,143
-599
-1% -$279K 0.43% 63
2025
Q3 		$25.9M Sell
61,742
-491
-0.8% -$165K 0.38% 70
2025
Q2 		$17.9M Buy
+62,233
New +$18.6M 0.27% 108
2016
Q1 		– Sell
-2,700
Closed -$423K – 925
2015
Q4 		$423K Sell
2,700
-2,000
-43% -$291K 0.01% 702
2015
Q3 		$617K Sell
4,700
-250
-5% -$40.1K 0.01% 649
2015
Q2 		$861K Buy
4,950
+2,450
+98% +$441K 0.01% 596
2015
Q1 		$431K Sell
2,500
-608
-20% -$92.7K 0.01% 751
2014
Q4 		$402K Sell
3,108
-85
-3% -$11K ﹤0.01% 754
2014
Q3 		$411K Sell
3,193
-1,413
-31% -$146K ﹤0.01% 665
2014
Q2 		$408K Sell
4,606
-1,245
-21% -$120K ﹤0.01% 776
2014
Q1 		$550K Buy
5,851
+501
+9% +$51.2K 0.01% 551
2013
Q4 		$605K Hold
5,350
– – 0.01% 542
2013
Q3 		$422K Sell
5,350
-250
-4% -$18.3K 0.01% 682
2013
Q2 		$369K Buy
+5,600
New +$361K 0.01% 715

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Tocqueville Asset Management's UTHR Position: Q2 2026 in Review

Tocqueville Asset Management increased its United Therapeutics (UTHR) stake by 19% in Q2 2026, buying an estimated $6.53M and bringing the position to 71,878 shares worth $38.9M. The position accounts for 0.51% of the portfolio, ranked #53.

Tocqueville Asset Management first reported a position in UTHR in Q2 2013 and has held it in 16 quarters since. 877 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Tocqueville Asset Management held 71,878 shares of United Therapeutics worth $38.9M as of Q2 2026.
  • Tocqueville Asset Management bought 11,595 United Therapeutics shares in Q2 2026, an estimated $6.53M.
  • United Therapeutics made up 0.51% of Tocqueville Asset Management's portfolio in Q2 2026, its #53 holding.
  • Tocqueville Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 16 quarters since.
  • 877 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.